ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
3 hedge funds and large institutions have $2.31M invested in ENVUE MEDICAL INC NEW in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
2.04% less ownership
Funds ownership: 14.31% → 12.27% (-2%)
10% less capital invested
Capital invested by funds: $2.58M → $2.31M (-$260K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$408K |
| 2 |
Millennium Management
New York
|
-$121K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
FEED Hedge Fund Activity: Q2 2018 in Review
3 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q2 2018, worth a combined $2.31M — down 10% from $2.58M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FEED and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Kennedy Capital Management, adding an estimated $121K. The largest seller was Sabby Management, exiting entirely with an estimated $408K sold.
- 3 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q2 2018, down from 5 in Q1 2018.
- Funds reported $2.31M of ENVUE MEDICAL INC NEW stock for Q2 2018, down 10% quarter-over-quarter.
- 0 funds opened new ENVUE MEDICAL INC NEW positions in Q2 2018 and 2 closed out, a net change of -2 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q2 2018 was Kennedy Capital Management, an estimated $121K added.
- The largest ENVUE MEDICAL INC NEW seller in Q2 2018 was Sabby Management, an estimated $408K sold.
Based on aggregated 13F filings for Q2 2018.